Records containing: Prostate Adenocarcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-30Optimizing Treatment and Advanced Multi-Imaging Response Evaluation for Very-High-Risk Prostate Cancer (OPTIMAL) - a Phase II Single Arm Study
-
CLINICAL_TRIALS study record update · 2026-10-30Phase 2 Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-10-29Magnetic Resonance Imaging (MRI) Derived Quantitative Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
-
CLINICAL_TRIALS study record update · 2026-10-27Phase 3, Multi-Center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging Men With Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy With Pelvic Lymph Node Dissection
-
CLINICAL_TRIALS study record update · 2026-10-27Phase 3, Multi-Center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging Men With Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy With Pelvic Lymph Node Dissection
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-10-27A Phase 2 Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy
-
CLINICAL_TRIALS study record update · 2026-10-27Phase 3, Multi-Center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging Men With Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy With Pelvic Lymph Node Dissection
-
CLINICAL_TRIALS study results posted · 2026-10-19TRAMP: Tumor Necrosis Factor- α Blockade and AR Inhibition in Men With CRPC
-
CLINICAL_TRIALS study results posted · 2026-08-24A Phase Ib/II Study of Intermittent Talazoparib Plus Temozolomide in Patients With Metastatic Castration Resistant Prostate Cancer and No Mutations in DNA Damage Repair
-
CLINICAL_TRIALS study record update · 2026-08-14Phase 3, Multi-Center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging Men With Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy With Pelvic Lymph Node Dissection
-
CLINICAL_TRIALS study results posted · 2026-07-20RAD 2003/XUAB2104: Randomized Phase II Trial of Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-04-27Prospective Trial of Combination External Beam Radiation Therapy and MRI-guided, Dose-differentiated High Dose-rate Prostate Brachytherapy Boost for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-04-27INSPIRE: INnovative SABR for Prostate Cancer All IREland
-
CLINICAL_TRIALS study record update · 2026-04-27Magnetic Resonance Imaging (MRI) Derived Quantitative Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
-
CLINICAL_TRIALS study record update · 2026-04-24High-Risk prostatE Cancer radiatiOn Versus surgERy (RECOVER)
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase II Trial of Focal Ultrahypofractionated Stereotactic Radiation Therapy for the Treatment of Unifocal Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-04-16Development &Amp; Evaluation of a Quantitative HP MRI Clinical Prostate Cancer Exam
-
CLINICAL_TRIALS study record update · 2026-04-15Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Prostate Cancer Without an Endorectal Coil
-
CLINICAL_TRIALS study record update · 2026-04-15A Phase 2 Course Determining Study for Men With Hormone-Naïve Metastatic Prostate Cancer (HNMPCa)
-
CLINICAL_TRIALS study record update · 2026-04-14Phase IB Study of Personalized Ultrahypofractionated Stereotactic Ablative Radiotherapy of High Risk PROstate Cancer Guided by PET PSMA (68Ga PMSA-11; Ilucix) Response (PULSAR ProPhet)
-
CLINICAL_TRIALS study record update · 2026-04-14TRAMP: Tumor Necrosis Factor- α Blockade and AR Inhibition in Men With CRPC
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 2 Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase I/II Study of High-Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-04-09A Phase 2 Trial of Radium Ra 223 Dichloride in Combination With Androgen Deprivation Therapy and Stereotactic Body Radiation Therapy for Patients With Oligometastatic Castration Sensitive Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-04-09Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer